Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
16.61
+0.31 (1.90%)
Nov 13, 2026, 4:00 PM EST - Market closed
Sotera Health Company Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,230 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 |
Revenue Growth | 6.90% | 5.74% | 4.88% | 4.54% | 7.75% | 13.85% |
Gross Profit Gross Profit Growth | 671.74 | 645.53 | 602.3 | 577.16 | 557 | 518.67 |
Operating Income Operating Income Growth | 452.04 | 414.33 | 335.51 | 326.99 | 327.89 | 305.53 |
Net Income Net Income Growth | 173.47 | 77.95 | 44.34 | 51.09 | -233.57 | 115.36 |
Earnings Per Share EPS Growth | 0.60 | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
EPS Growth | 207.06% | 72.20% | -12.89% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sterigenics Sterigenics Growth | 805.42 | 755.78 | 697.85 | 667.13 | 626.65 | 571.83 |
Nordion Nordion Growth | 196.01 | 187.62 | 173.36 | 160.46 | 153.64 | 140.51 |
Nelson Labs Nelson Labs Growth | 228.32 | 220.22 | 229.23 | 221.7 | 223.4 | 219.14 |
Revenue (Total) Revenue (Total) Growth | 1,230 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 412.66 | 344.9 | 278.05 | 297.12 | 395.87 | 107.54 |
Total Debt Total Debt Growth | 2,276 | 2,276 | 2,351 | 2,327 | 2,032 | 1,828 |
Net Cash (Debt) Net Cash Growth | -1,863 | -1,931 | -2,073 | -2,030 | -1,636 | -1,720 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6.47 | -6.74 | -7.27 | -7.17 | -5.84 | -6.16 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 331.58 | 287.2 | 224.16 | -147.73 | 277.96 | 281.55 |
Capital Expenditures CapEx Growth | -196.15 | -138.02 | -179.07 | -214.98 | -182.38 | -102.16 |
Free Cash Flow Free Cash Flow Growth | 135.43 | 149.18 | 45.09 | -362.71 | 95.58 | 179.38 |
Free Cash Flow Growth | 56.36% | 230.81% | - | - | -46.72% | 167.42% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.62% | 55.48% | 54.73% | 55.01% | 55.50% | 55.68% |
Operating Margin | 36.76% | 35.61% | 30.49% | 31.16% | 32.67% | 32.80% |
Pretax Margin | 22.35% | 12.68% | 10.35% | 10.10% | -24.22% | 18.86% |
Profit Margin | 14.11% | 6.70% | 4.03% | 4.87% | -23.27% | 12.38% |
FCF Margin | 11.01% | 12.82% | 4.10% | -34.57% | 9.52% | 19.26% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.69 | 64.29 | 87.39 | 93.21 | - | 57.76 |
Forward PE | 16.02 | 19.12 | 18.03 | 18.81 | 8.38 | 24.18 |
P/FCF Ratio | 35.03 | 33.59 | 85.93 | - | 24.59 | 37.14 |
PS Ratio | 3.86 | 4.31 | 3.52 | 4.54 | 2.34 | 7.15 |